transparency
Big data ‘road map’ launched by ABPI
November 22, 2013Medical Communications, Research and Development, Sales and Marketing ABPI, BMA, NIHR, data, transparency
The ABPI has launched a new initiative that aims to harness the potential of big data to improve patient care …
EMA looks to sharpen HTA data output
November 20, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EMA, NICE, hta, transparency
The European Medicines Agency (EMA) has deepened its partnership with the European network for Health Technology Assessment (EUnetHTA) as it …
EMA delays data transparency
November 14, 2013Medical Communications, Research and Development, Sales and Marketing EMA, FDA, all trials, transparency
The European Medicines Agency has delayed its much-trailed plan to launch a clear policy on making clinical trial data publically …
LEO Pharma to release clinical trial data
October 24, 2013Research and Development, Sales and Marketing Goldacre, LEO Pharma, all trials, transparency
LEO Pharma has announced that it will start releasing clinical trial data from studies dating back to almost 25 years …
Trials and tribulations
October 14, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, eric low, myeloma, transparency
I have been chief executive of Myeloma UK since its inception 17 years ago, and its unique bedside to bench …
EMA bows to pressure on its own transparency
October 8, 2013Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Guido Rasi, transparency
The European Medicines Agency (EMA)’s management board has agreed to publish agendas and minutes from the meetings of all the …
The future of data disclosure in Europe
September 30, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, FDA, GSK, transparency
The debate of clinical trial transparency has at times appeared a peculiarly British issue, but plans are afoot in Europe …
UK trial rules tightened up
September 11, 2013Research and Development, Sales and Marketing all trials, hra, transparency
Anyone wanting to conduct clinical trials in the UK will have to register their research in order to receive a …
ABPI publishes trial disclosure ‘toolkit’
August 15, 2013Medical Communications, Sales and Marketing ABPI, EFPIA, Goldacre, transparency
The ABPI has today launched a new clinical trial disclosure toolkit to help pharma companies meet data transparency requirements. The …
AllTrials campaign releases manifesto
August 9, 2013Medical Communications, Research and Development, Sales and Marketing Bad pharma, GSK, Goldacre, NICE, transparency
The UK clinical trial transparency initiative AllTrials has released its first detailed manifesto as it looks to ramp up pressure …
GSK sales up – impact of China allegations to follow
July 24, 2013Sales and Marketing GSK, Q2, Seretide, Seroxat, Witty, bribery, transparency
GlaxoSmithKline has reported a modest rise in sales but the fallout from China’s bribery probe dominates the firm’s release of …
Pharma groups want limited data release
July 24, 2013Research and Development, Sales and Marketing EFPIA, Goldacre, PhRMA, all trials, transparency
The two main US and European pharma lobby groups have released a joint statement saying they welcome independent reviews of …
Secret EFPIA memo on data transparency leaked
July 22, 2013Medical Communications, Research and Development, Sales and Marketing ABPI, EFPIA, EMA, PhRMA, transparency
A memo from the European pharma lobby group EFPIA has revealed that the industry is trying to ‘mobilise’ patient groups …
Tighter rules on pharma gifts challenged by manufacturers
July 4, 2013Manufacturing and Production, Medical Communications, Sales and Marketing EFPIA, EPPA, promotional products, transparency
The pharma industry could face a series of lawsuits by manufacturers of promotional gifts as new rules look to ban …
Pharma to disclose doctor payments
July 4, 2013Medical Communications, Research and Development, Sales and Marketing ABPI, EFPIA, pharma, transparency
Pharma companies in Europe will have to reveal how much they pay to doctors under a voluntary agreement set out …
Latest content
Five Facts about cardiovascular disease
